-Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies

Purpose: The aims of the study were to develop and evaluate a novel residualizing peptide for labeling internalizing antibodies with 124 I to support clinical development using immuno-positron emission tomography (PET). Methods: The anti-epidermal growth factor receptor antibody ch806 was radiolabel...

Full description

Saved in:
Bibliographic Details
Main Authors: Fook T. Lee PhD, Ingrid J. G. Burvenich PhD, Nancy Guo MBBS, MSc, Pece Kocovski BSc (Honors), Henri Tochon-Danguy PhD, Uwe Ackermann PhD, Graeme J. O’Keefe PhD, Sylvia Gong PhD, Angela Rigopoulos BSc, MSc, Zhanqi Liu MBBS, PhD, Hui K. Gan MBBS, FRACP, PhD, Andrew M. Scott MBBS, FRACP, MD
Format: Article
Language:English
Published: SAGE Publishing 2016-06-01
Series:Molecular Imaging
Online Access:https://doi.org/10.1177/1536012116647535
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841563183660138496
author Fook T. Lee PhD
Ingrid J. G. Burvenich PhD
Nancy Guo MBBS, MSc
Pece Kocovski BSc (Honors)
Henri Tochon-Danguy PhD
Uwe Ackermann PhD
Graeme J. O’Keefe PhD
Sylvia Gong PhD
Angela Rigopoulos BSc, MSc
Zhanqi Liu MBBS, PhD
Hui K. Gan MBBS, FRACP, PhD
Andrew M. Scott MBBS, FRACP, MD
author_facet Fook T. Lee PhD
Ingrid J. G. Burvenich PhD
Nancy Guo MBBS, MSc
Pece Kocovski BSc (Honors)
Henri Tochon-Danguy PhD
Uwe Ackermann PhD
Graeme J. O’Keefe PhD
Sylvia Gong PhD
Angela Rigopoulos BSc, MSc
Zhanqi Liu MBBS, PhD
Hui K. Gan MBBS, FRACP, PhD
Andrew M. Scott MBBS, FRACP, MD
author_sort Fook T. Lee PhD
collection DOAJ
description Purpose: The aims of the study were to develop and evaluate a novel residualizing peptide for labeling internalizing antibodies with 124 I to support clinical development using immuno-positron emission tomography (PET). Methods: The anti-epidermal growth factor receptor antibody ch806 was radiolabeled directly or indirectly with isotopes and various residualizing peptides. Azido-derivatized radiolabeled peptides were conjugated to dibenzylcyclooctyne-derivatized ch806 antibody via click chemistry. The radiochemical purities, antigen-expressing U87MG.de2-7 human glioblastoma cell-binding properties, and targeting of xenografts at 72 hours post injection of all radioconjugates were compared. Biodistribution of 124 I-PEG 4 -tptddYddtpt-ch806 and immuno-PET imaging were evaluated in tumor-bearing mice. Results: Biodistribution studies using xenografts at 72 hours post injection showed that 131 I-PEG 4 -tptddYddtpt-ch806 tumor uptake was similar to 111 In-CHX-A″-DTPA-ch806. 125 I-PEG 4 -tptddyddtpt-ch806 showed a lower tumor uptake value but higher than directly labeled 125 I-ch806. 124 I-PEG 4 -tptddYddtpt-ch806 was produced at 23% labeling efficiency, 98% radiochemical purity, 25.9 MBq/mg specific activity, and 64% cell binding in the presence of antigen excess. Tumor uptake for 124 I-PEG 4 -tptddYddtpt-ch806 was similar to 111 In-CHX-A″-DTPA-ch806. High-resolution immuno-PET/magnetic resonance imaging of tumors showed good correlation with biodistribution data. Conclusions: The mixed d / l -enantiomeric peptide, d Thr- d Pro- d Thr- dA sp -dA sp-Tyr -dA sp -dA sp- d Thr- d Pro- d Thr, is suitable for radiolabeling antibodies with radiohalogens such as 124 I for high-resolution immuno-PET imaging of tumors and for evaluation in early-phase clinical trials.
format Article
id doaj-art-ec906d2158ff44d483cd65511d1e09d3
institution Kabale University
issn 1536-0121
language English
publishDate 2016-06-01
publisher SAGE Publishing
record_format Article
series Molecular Imaging
spelling doaj-art-ec906d2158ff44d483cd65511d1e09d32025-01-03T00:10:43ZengSAGE PublishingMolecular Imaging1536-01212016-06-011510.1177/153601211664753510.1177_1536012116647535-Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing AntibodiesFook T. Lee PhD0Ingrid J. G. Burvenich PhD1Nancy Guo MBBS, MSc2Pece Kocovski BSc (Honors)3Henri Tochon-Danguy PhD4Uwe Ackermann PhD5Graeme J. O’Keefe PhD6Sylvia Gong PhD7Angela Rigopoulos BSc, MSc8Zhanqi Liu MBBS, PhD9Hui K. Gan MBBS, FRACP, PhD10Andrew M. Scott MBBS, FRACP, MD11 Tumour Targeting Program, Ludwig Institute For Cancer Research and Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Tumour Targeting Program, Ludwig Institute For Cancer Research and Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Tumour Targeting Program, Ludwig Institute For Cancer Research and Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Tumour Targeting Program, Ludwig Institute For Cancer Research and Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Tumour Targeting Program, Ludwig Institute For Cancer Research and Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Tumour Targeting Program, Ludwig Institute For Cancer Research and Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Tumour Targeting Program, Ludwig Institute For Cancer Research and Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, AustraliaPurpose: The aims of the study were to develop and evaluate a novel residualizing peptide for labeling internalizing antibodies with 124 I to support clinical development using immuno-positron emission tomography (PET). Methods: The anti-epidermal growth factor receptor antibody ch806 was radiolabeled directly or indirectly with isotopes and various residualizing peptides. Azido-derivatized radiolabeled peptides were conjugated to dibenzylcyclooctyne-derivatized ch806 antibody via click chemistry. The radiochemical purities, antigen-expressing U87MG.de2-7 human glioblastoma cell-binding properties, and targeting of xenografts at 72 hours post injection of all radioconjugates were compared. Biodistribution of 124 I-PEG 4 -tptddYddtpt-ch806 and immuno-PET imaging were evaluated in tumor-bearing mice. Results: Biodistribution studies using xenografts at 72 hours post injection showed that 131 I-PEG 4 -tptddYddtpt-ch806 tumor uptake was similar to 111 In-CHX-A″-DTPA-ch806. 125 I-PEG 4 -tptddyddtpt-ch806 showed a lower tumor uptake value but higher than directly labeled 125 I-ch806. 124 I-PEG 4 -tptddYddtpt-ch806 was produced at 23% labeling efficiency, 98% radiochemical purity, 25.9 MBq/mg specific activity, and 64% cell binding in the presence of antigen excess. Tumor uptake for 124 I-PEG 4 -tptddYddtpt-ch806 was similar to 111 In-CHX-A″-DTPA-ch806. High-resolution immuno-PET/magnetic resonance imaging of tumors showed good correlation with biodistribution data. Conclusions: The mixed d / l -enantiomeric peptide, d Thr- d Pro- d Thr- dA sp -dA sp-Tyr -dA sp -dA sp- d Thr- d Pro- d Thr, is suitable for radiolabeling antibodies with radiohalogens such as 124 I for high-resolution immuno-PET imaging of tumors and for evaluation in early-phase clinical trials.https://doi.org/10.1177/1536012116647535
spellingShingle Fook T. Lee PhD
Ingrid J. G. Burvenich PhD
Nancy Guo MBBS, MSc
Pece Kocovski BSc (Honors)
Henri Tochon-Danguy PhD
Uwe Ackermann PhD
Graeme J. O’Keefe PhD
Sylvia Gong PhD
Angela Rigopoulos BSc, MSc
Zhanqi Liu MBBS, PhD
Hui K. Gan MBBS, FRACP, PhD
Andrew M. Scott MBBS, FRACP, MD
-Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
Molecular Imaging
title -Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
title_full -Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
title_fullStr -Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
title_full_unstemmed -Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
title_short -Tyrosine Confers Residualizing Properties to a -Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies
title_sort tyrosine confers residualizing properties to a amino acid rich residualizing peptide for radioiodination of internalizing antibodies
url https://doi.org/10.1177/1536012116647535
work_keys_str_mv AT fooktleephd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT ingridjgburvenichphd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT nancyguombbsmsc tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT pecekocovskibschonors tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT henritochondanguyphd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT uweackermannphd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT graemejokeefephd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT sylviagongphd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT angelarigopoulosbscmsc tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT zhanqiliumbbsphd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT huikganmbbsfracpphd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies
AT andrewmscottmbbsfracpmd tyrosineconfersresidualizingpropertiestoaaminoacidrichresidualizingpeptideforradioiodinationofinternalizingantibodies